SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-026895
Filing Date
2022-10-24
Accepted
2022-10-24 16:41:16
Documents
3
Period of Report
2022-10-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prime-closing8xk102222.htm 8-K 23742
2 EX-3.1 exhibit31-closing8xk.htm EX-3.1 38180
3 EX-3.2 exhibit32-closing8xk.htm EX-3.2 144789
  Complete submission text file 0001628280-22-026895.txt   207829
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 221326383
SIC: 2836 Biological Products, (No Diagnostic Substances)